尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the full record of transactions filed by Aggarwal Sumit, 董事长兼首席执行官. Director active across 1 company, notably Eloxx Pharmaceuticals, Inc.. Aggregated, 3 disclosures have been published. Activity tracked since 1 December 2021. The latest transaction was filed on 24 January 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Sumit Aggarwal is the President and CEO of Eloxx Pharmaceuticals, Inc. He leads the company by setting the strategic vision and overseeing daily operations. His leadership is essential for the development of innovative therapeutic solutions.